Cite
MLA Citation
Daniel Castellano et al.. “Everolimus Plus Octreotide Long‐Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT‐2 Study.” Oncologist, vol. 18, 2013, pp. 46–53. http://access.bl.uk/ark:/81055/vdc_100054377003.0x000021